Title: 2009 NIH Director’s Pioneer Award Program (DP1)
This is reissue of RFA-RM-08-013.
Request for Applications (RFA) Number: RFA-RM-09-001
Opening Date: April 15, 2009 (Earliest date an application may be submitted to Grants.gov)
Application Due Date(s): May 15, 2009
Reference Letter Submission/Receipt Dates: April 15, 2009 – 5:00 pm (EDT) May 15, 2009
Additional Information: To Be Available Date (October 17, 2008): Frequently Asked Questions (FAQs) at http://nihroadmap.nih.gov/pioneer/faq.apsx
Purpose. The NIH Director’s Pioneer Award Program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transformative approaches to addressing major biomedical or behavioral challenges. To be considered pioneering, the proposed research must reflect ideas substantially different from those already being pursued in the investigator’s laboratory or elsewhere. The NIH Director’s Pioneer Award Program is a High-Risk Research initiative of the NIH Roadmap for Medical Research. The 2009 Pioneer Award competition will proceed in two phases. The first phase is a pre-application phase in response to PAR-09-012. Pre-applications will be evaluated by a group of external reviewers, and those investigators whose submissions are judged to be the most outstanding will be notified of the opportunity to submit full applications under this FOA. The 2009 Pioneer awardees will be selected from this group of applicants.
Mechanism of Support. This FOA will utilize the DP1 grant mechanism. Pre-applications for 2009 Pioneer Awards were solicited under PAR-09-012. Applicants must read both FOAs.
Funds Available and Anticipated Number of Awards. Total funding available is approximately $5 million for the five-year period. It is anticipated that at least 5-10 awards will be made in 2009.
Budget and Project Period. Awards will be for up to $500,000 in direct costs each year for five years.
Eligible Project Directors/Principal Investigators (PDs/PIs). Only investigators who submitted a pre-application (X02), in response to PAR-09-012 are eligible to submit full applications under this FOA. Recipients of the Pioneer Award (DP1) are required to commit the major portion (at least 51%) of their research effort to activities supported by the Pioneer Award. Applicants who were not selected for an award in prior years may submit pre-applications this year. There are no citizenship or residency requirements.
This announcement utilizes the DP1 award mechanism. The Project Director/Principal Investigator (PD/PI) will be solely responsible for planning, directing, and executing the proposed project.
This is a Roadmap initiative. The NIH Common Fund has set aside sufficient funds in FY2009 to provide at least 5-10 awards, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Awards will be for up to $500,000 in direct costs each year for five years, plus applicable Facilities and Administrative costs to be determined at the time of award.
NIH grants policies as described in the PAR-09-012 to be eligible to submit a full application in response to this FOA. The full application may not be significantly different from what was proposed in the X02 application. Significant differences between the full application and the X02 may result in the full application not being reviewed.
Recipients of the Pioneer Award (DP1) are required to commit the major portion (at least 51%) of their research effort to activities supported by the Pioneer Award. Applicants who were not selected for an award in prior years may submit pre-applications this year. There are no citizenship or residency requirements. NIH intramural investigators are not eligible for support under this program.
Resubmissions of applications will not be allowed under this FOA.
Renewals applications are not allowed under this FOA.
Applicants may submit only one application as a PD/PI in response to this FOA. There is no limit to the number of applications institutions may submit. All applications will be considered “new” applications, regardless of any previous applications to the Pioneer Award Program.
The individual(s) designated as PDs/PIs on the application must be registered also in the NIH eRA Commons.
The application items include all those required for the Pioneer Award pre-applications (X02) submitted under PAR-09-012. The contents of these items must be substantially the same as those submitted in the pre-application. In addition, applicants submitting full applications in response to this FOA must arrange to have three letters of reference submitted on their behalf and must submit information on human and animal subjects.
The following instructions are specific to the Pioneer Award (DP1) applications and are exceptions to the general SF424 instructions. Applications that do not conform to the specific instructions detailed below will not be reviewed.
All of the following must be submitted on the SF424 (R&R) Other Project Information Component for the application to be considered complete. The text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed.
I. Abstract: The abstract text, which describes the goals of the project, must be substantially the same as that submitted for the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed. As indicated in PAR-09-012, the abstract must have no more than 300 words and must not exceed one page. The abstract must contain text only – no figures, animations, or web links to provide further information.
III. Essay: The essay text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed. For completeness, a description of the essay requirements as indicated in PAR-09-012 follows. An essay of 3-5 pages that addresses the investigator's innovative vision for, and the significance of, the biomedical or behavioral problem to be addressed, and the investigator’s qualifications to engage in groundbreaking research. The essay should describe the investigator’s view of the major challenges in biomedical or behavioral research to which he/she can make seminal contributions. The scientific plan should be provided in broad terms because the research plan is expected to evolve during the tenure of the grant. The essay should include the following in the order given with the headings as shown:
Literature references are not required but if included must fit within the five-page limit. Figures and illustrations may be included but must also fit within the five-page limit. Do no include links to websites to provide further information. No animations (movies) are allowed in any documents.
Note that the description of the most significant research accomplishment and the human subjects/animal subjects information also will be attached using this item number.
IV. Summary of the Investigator’s Most Significant Research Accomplishment. The text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as correction of typographical errors, will be allowed. This is limited to one page. Publications or similar documents will not be accepted.
V. Biographical Sketch: A two-page biographical sketch for the PD/PI only. (Use the sample format shown in the URL in Section 4.5.2 of the Application Guide (omitting Section C, Research Support). Only the Biographical Sketch of the applicant should be submitted. No other persons should be designated as key personnel and no other biographical sketches should be uploaded.
VI. List of Current and Pending Research Support: A list of current and pending research support from all sources, including current year direct costs and percent effort devoted to each project. (Use the format shown in Section 3.1.1.8 of the Application Guide.) The effort commitment statement (described below) must be included in this document. Applicants must also provide a brief statement of the facilities to be used for the conduct of the research in this document.
VII. Effort Commitment: Awardees are required to commit at least 51% of their research effort to the project supported by the Pioneer Award. Applicants must include a statement to indicate that, if chosen to receive an award, the applicant will commit a minimum of 51% of his/her research effort to the project supported by the Pioneer Award. This statement must be included in the list of current and pending support.
VIII. Human Subjects / Animal Subjects: If applicable, provide information regarding human subjects protection, inclusion plans, animal welfare, IRB, and IACUC assurance as described in the SF424 instructions.
IX. Letters of Reference: Applicants must arrange to have three (and no more than three) letters of reference submitted on their behalf. Applications with fewer than three letters of reference may be considered non-responsive and may not be reviewed. Late letters will not be accepted. Applicants are responsible for monitoring the submission of their letters to ensure that three letters have been submitted prior to the submission deadline. Applicants can check the status of their letters in the application grant folder in the Commons.
Referees may submit letters from April 15, 2009 to 5:00 pm (EDT), May 15, 2009 at https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new (Note: The letter writer does not need a Commons account to submit a letter.)
To submit letters, referees will need the following information from the applicant:
• Funding Opportunity Number (FOA) for this announcement RFA-RM-09-001;
• The applicant’s Commons User Name (Note: Referees do not have to be registered in the Commons and do not need their own Commons User Name – only the Commons User Name of the applicant is required);
• The applicant’s last name (note – the name must match exactly the applicant’s name in the Commons);
• The URL to the letter submission page (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new)
Applicants are encouraged to send the instructions for referees at (http://nihroadmap.nih.gov/pioneer/LettersofReferenceFormat.aspx) to each of their referees along with the information above. Letters of reference are confidential. Applicants will not have access to the letters.
Email confirmations will be sent to the applicant and the referee. The confirmation sent to the applicant will include the referee’s name and the date and time the letter was submitted. The confirmation sent to the referee will include the referee and applicant’s names, a confirmation number, and the date and time the letter was submitted. Referees should record the confirmation number as it is required when submitting revisions to reference letters.
Note: Because email can be unreliable, it is the applicant’s responsibility to check the status of his/her letters of reference periodically in the Commons.
beginning April 15, 2009, and must be submitted no later than 5:00 p.m. (EDT), May 15, 2009. Late letters will not be accepted and applications with fewer than three letters may not be reviewed. Letters must be submitted electronically – paper copies will not be accepted.
In two pages or less, describe the applicant’s qualities that support his/her claim to scientific innovativeness and creativity. When possible, give specific examples that illustrate these qualities. Address the likelihood that the applicant will conduct groundbreaking research in the proposed research area.
The following information is required and must be entered on the letter submission page at the time of submission:
Note: The letter submission page can be accessed without signing into the Commons, and referees do not have to be registered in the Commons. Referees must provide the applicant’s Commons User Name and the other information detailed in this section.
Applicant Information (to be provided to referees by applicants):
Funding Opportunity Number (FOA) of this announcement RFA-RM-09-001 (Required)
Confirmation Number (Required only when resubmitting a letter for the current FOA)
Email confirmations will be sent to both the applicant and the referee following submission of the letter. The email confirmation will include a Confirmation Number that will be required when resubmitting letters. Please print the confirmation email for your records.
Note: If you submitted letters for Pioneer Award applicants in a prior year, you must submit new letters of reference this year. Previously submitted letters will not be retrieved.
Please see the detailed instructions on submitting letters of reference at http://nihroadmap.nih.gov/pioneer/LettersofReferenceFormat.aspx and the Frequently Asked Questions at http://nihroadmap.nih.gov/pioneer/faq.aspx. Send questions to Pioneer@NIH.gov.
The Budget request is entered in the Estimated Project Funding section of the SF424 (R&R) Cover component only. Awards are for up to $2.5 million in direct costs for the five-year budget/project period. Funds may be requested for personnel (including co-investigators and collaborators), supplies, equipment, sub-contracts, and other allowable costs. Only the five-year total – $2.5 million - should be entered. A detailed budget is not requested and will not be accepted.
Reference Letter Submission Dates: April 15, 2009 – May 15, 2009
Advisory Council to the Director Review Date(s): August 2009
Review of applications for this FOA will be conducted by an interview process. Investigators with outstanding submissions will be interviewed by a panel of distinguished external scientists. The interviews will be held in June 2009 on or near the NIH Campus in Bethesda, MD. A second level of review will be conducted, without further interviews, by the Advisory Committee to the Director (ACD), NIH. The Director, NIH, will make the final selection of awardees based on the evaluations of the interview panel, the recommendations of the ACD, and programmatic considerations. Final selections will be announced publicly, and awards made, by the end of September 2009.
Applications that are complete and responsive to this FOA will be evaluated for scientific and technical merit by an appropriate peer review group in accordance with NIH peer review procedures (http://grants1.nih.gov/grants/peer/), using the review criteria stated below.
Applications will be evaluated based on the likelihood that the applicant will pursue a pioneering approach to a problem of relevance to biomedical or behavioral research, In particular, reviewers will evaluate:
The investigator: Evidence for the investigator’s claim of innovativeness/creativity (taking into consideration the investigator’s career stage) and the demonstrated ability of the investigator to devote at least 51% of his/her effort on to activities supported by the Pioneer Award.
The suitability for Pioneer Award mechanism: Evidence that the proposed project carries much higher levels of risk and potential impact than typical of NIH-supported research projects and evidence that the proposed project represents a distinctly new scientific direction.
Will be expected if an award is considered likely, or an explanation of why sharing is not possible.
Awardees will be notified in August 2009. Public announcement of the awards will be made in September 2009. Awards will begin September 30, 2009.
1. This award provides funding for an application submitted in response to RFA OD-09-001. This grant should be administered in accordance with the guidelines described in this specific announcement. These guidelines are in addition to the standard “Terms and Conditions” referenced in Section III of this Notice of Grant Award.
2a. When issuing statements, press releases, and other documents describing projects or programs funded as a NIH Director’s Pioneer Award, please use the following acknowledgement: "This work was funded by the National Institutes of Health through the NIH Director's Pioneer Award Program, grant number DP1-OD-xxxxxx. Information on the Pioneer Award Program is at http://nihroadmap.nih.gov/pioneer/.
2b. As indicated in the FOA, awardees are expected to commit at least 51% of their research effort to the project supported by the Pioneer Award.
Title: 2009 NIH Director’s Pioneer Award Program (DP1)
This is reissue of RFA-RM-08-013.
Request for Applications (RFA) Number: RFA-RM-09-001
Opening Date: April 15, 2009 (Earliest date an application may be submitted to Grants.gov)
Application Due Date(s): May 15, 2009
Reference Letter Submission/Receipt Dates: April 15, 2009 – 5:00 pm (EDT) May 15, 2009
Additional Information: To Be Available Date (October 17, 2008): Frequently Asked Questions (FAQs) at http://nihroadmap.nih.gov/pioneer/faq.apsx
Purpose. The NIH Director’s Pioneer Award Program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transformative approaches to addressing major biomedical or behavioral challenges. To be considered pioneering, the proposed research must reflect ideas substantially different from those already being pursued in the investigator’s laboratory or elsewhere. The NIH Director’s Pioneer Award Program is a High-Risk Research initiative of the NIH Roadmap for Medical Research. The 2009 Pioneer Award competition will proceed in two phases. The first phase is a pre-application phase in response to PAR-09-012. Pre-applications will be evaluated by a group of external reviewers, and those investigators whose submissions are judged to be the most outstanding will be notified of the opportunity to submit full applications under this FOA. The 2009 Pioneer awardees will be selected from this group of applicants.
Mechanism of Support. This FOA will utilize the DP1 grant mechanism. Pre-applications for 2009 Pioneer Awards were solicited under PAR-09-012. Applicants must read both FOAs.
Funds Available and Anticipated Number of Awards. Total funding available is approximately $5 million for the five-year period. It is anticipated that at least 5-10 awards will be made in 2009.
Budget and Project Period. Awards will be for up to $500,000 in direct costs each year for five years.
Eligible Project Directors/Principal Investigators (PDs/PIs). Only investigators who submitted a pre-application (X02), in response to PAR-09-012 are eligible to submit full applications under this FOA. Recipients of the Pioneer Award (DP1) are required to commit the major portion (at least 51%) of their research effort to activities supported by the Pioneer Award. Applicants who were not selected for an award in prior years may submit pre-applications this year. There are no citizenship or residency requirements.
This announcement utilizes the DP1 award mechanism. The Project Director/Principal Investigator (PD/PI) will be solely responsible for planning, directing, and executing the proposed project.
This is a Roadmap initiative. The NIH Common Fund has set aside sufficient funds in FY2009 to provide at least 5-10 awards, contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Awards will be for up to $500,000 in direct costs each year for five years, plus applicable Facilities and Administrative costs to be determined at the time of award.
NIH grants policies as described in the PAR-09-012 to be eligible to submit a full application in response to this FOA. The full application may not be significantly different from what was proposed in the X02 application. Significant differences between the full application and the X02 may result in the full application not being reviewed.
Recipients of the Pioneer Award (DP1) are required to commit the major portion (at least 51%) of their research effort to activities supported by the Pioneer Award. Applicants who were not selected for an award in prior years may submit pre-applications this year. There are no citizenship or residency requirements. NIH intramural investigators are not eligible for support under this program.
Resubmissions of applications will not be allowed under this FOA.
Renewals applications are not allowed under this FOA.
Applicants may submit only one application as a PD/PI in response to this FOA. There is no limit to the number of applications institutions may submit. All applications will be considered “new” applications, regardless of any previous applications to the Pioneer Award Program.
The individual(s) designated as PDs/PIs on the application must be registered also in the NIH eRA Commons.
The application items include all those required for the Pioneer Award pre-applications (X02) submitted under PAR-09-012. The contents of these items must be substantially the same as those submitted in the pre-application. In addition, applicants submitting full applications in response to this FOA must arrange to have three letters of reference submitted on their behalf and must submit information on human and animal subjects.
The following instructions are specific to the Pioneer Award (DP1) applications and are exceptions to the general SF424 instructions. Applications that do not conform to the specific instructions detailed below will not be reviewed.
All of the following must be submitted on the SF424 (R&R) Other Project Information Component for the application to be considered complete. The text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed.
I. Abstract: The abstract text, which describes the goals of the project, must be substantially the same as that submitted for the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed. As indicated in PAR-09-012, the abstract must have no more than 300 words and must not exceed one page. The abstract must contain text only – no figures, animations, or web links to provide further information.
III. Essay: The essay text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as fixing typographical errors, will be allowed. For completeness, a description of the essay requirements as indicated in PAR-09-012 follows. An essay of 3-5 pages that addresses the investigator's innovative vision for, and the significance of, the biomedical or behavioral problem to be addressed, and the investigator’s qualifications to engage in groundbreaking research. The essay should describe the investigator’s view of the major challenges in biomedical or behavioral research to which he/she can make seminal contributions. The scientific plan should be provided in broad terms because the research plan is expected to evolve during the tenure of the grant. The essay should include the following in the order given with the headings as shown:
Literature references are not required but if included must fit within the five-page limit. Figures and illustrations may be included but must also fit within the five-page limit. Do no include links to websites to provide further information. No animations (movies) are allowed in any documents.
Note that the description of the most significant research accomplishment and the human subjects/animal subjects information also will be attached using this item number.
IV. Summary of the Investigator’s Most Significant Research Accomplishment. The text must be substantially the same as that submitted in the pre-application in response to PAR-09-012. Only minor changes, such as correction of typographical errors, will be allowed. This is limited to one page. Publications or similar documents will not be accepted.
V. Biographical Sketch: A two-page biographical sketch for the PD/PI only. (Use the sample format shown in the URL in Section 4.5.2 of the Application Guide (omitting Section C, Research Support). Only the Biographical Sketch of the applicant should be submitted. No other persons should be designated as key personnel and no other biographical sketches should be uploaded.
VI. List of Current and Pending Research Support: A list of current and pending research support from all sources, including current year direct costs and percent effort devoted to each project. (Use the format shown in Section 3.1.1.8 of the Application Guide.) The effort commitment statement (described below) must be included in this document. Applicants must also provide a brief
 statement of the facilities to be used for the conduct of the research in this document.
VII. Effort Commitment: Awardees are required to commit at least 51% of their research effort to the project supported by the Pioneer Award. Applicants must include a statement to indicate that, if chosen to receive an award, the applicant will commit a minimum of 51% of his/her research effort to the project supported by the Pioneer Award. This statement must be included in the list of current and pending support.
VIII. Human Subjects / Animal Subjects: If applicable, provide information regarding human subjects protection, inclusion plans, animal welfare, IRB, and IACUC assurance as described in the SF424 instructions.
IX. Letters of Reference: Applicants must arrange to have three (and no more than three) letters of reference submitted on their behalf. Applications with fewer than three letters of reference may be considered non-responsive and may not be reviewed. Late letters will not be accepted. Applicants are responsible for monitoring the submission of their letters to ensure that three letters have been submitted prior to the submission deadline. Applicants can check the status of their letters in the application grant folder in the Commons.
Referees may submit letters from April 15, 2009 to 5:00 pm (EDT), May 15, 2009 at https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new (Note: The letter writer does not need a Commons account to submit a letter.)
To submit letters, referees will need the following information from the applicant:
• Funding Opportunity Number (FOA) for this announcement RFA-RM-09-001;
• The applicant’s Commons User Name (Note: Referees do not have to be registered in the Commons and do not need their own Commons User Name – only the Commons User Name of the applicant is required);
• The applicant’s last name (note – the name must match exactly the applicant’s name in the Commons);
• The URL to the letter submission page (https://public.era.nih.gov/commons/public/reference/submitReferenceLetter.do?mode=new)
Applicants are encouraged to send the instructions for referees at (http://nihroadmap.nih.gov/pioneer/LettersofReferenceFormat.aspx) to each of their referees along with the information above. Letters of reference are confidential. Applicants will not have access to the letters.
Email confirmations will be sent to the applicant and the referee. The confirmation sent to the applicant will include the referee’s name and the date and time the letter was submitted. The confirmation sent to the referee will include the referee and applicant’s names, a confirmation number, and the date and time the letter was submitted. Referees should record the confirmation number as it is required when submitting revisions to reference letters.
Note: Because email can be unreliable, it is the applicant’s responsibility to check the status of his/her letters of reference periodically in the Commons.
beginning April 15, 2009, and must be submitted no later than 5:00 p.m. (EDT), May 15, 2009. Late letters will not be accepted and applications with fewer than three letters may not be reviewed. Letters must be submitted electronically – paper copies will not be accepted.
In two pages or less, describe the applicant’s qualities that support his/her claim to scientific innovativeness and creativity. When possible, give specific examples that illustrate these qualities. Address the likelihood that the applicant will conduct groundbreaking research in the proposed research area.
The following information is required and must be entered on the letter submission page at the time of submission:
Note: The letter submission page can be accessed without signing into the Commons, and referees do not have to be registered in the Commons. Referees must provide the applicant’s Commons User Name and the other information detailed in this section.
Applicant Information (to be provided to referees by applicants):
Funding Opportunity Number (FOA) of this announcement RFA-RM-09-001 (Required)
Confirmation Number (Required only when resubmitting a letter for the current FOA)
Email confirmations will be sent to both the applicant and the referee following submission of the letter. The email confirmation will include a Confirmation Number that will be required when resubmitting letters. Please print the confirmation email for your records.
Note: If you submitted letters for Pioneer Award applicants in a prior year, you must submit new letters of reference this year. Previously submitted letters will not be retrieved.
Please see the detailed instructions on submitting letters of reference at http://nihroadmap.nih.gov/pioneer/LettersofReferenceFormat.aspx and the Frequently Asked Questions at http://nihroadmap.nih.gov/pioneer/faq.aspx. Send questions to Pioneer@NIH.gov.
The Budget request is entered in the Estimated Project Funding section of the SF424 (R&R) Cover component only. Awards are for up to $2.5 million in direct costs for the five-year budget/project period. Funds may be requested for personnel (including co-investigators and collaborators), supplies, equipment, sub-contracts, and other allowable costs. Only the five-year total – $2.5 million - should be entered. A detailed budget is not requested and will not be accepted.
Reference Letter Submission Dates: April 15, 2009 – May 15, 2009
Advisory Council to the Director Review Date(s): August 2009
Review of applications for this FOA will be conducted by an interview process. Investigators with outstanding submissions will be interviewed by a panel of distinguished external scientists. The interviews will be held in June 2009 on or near the NIH Campus in Bethesda, MD. A second level of review will be conducted, without further interviews, by the Advisory Committee to the Director (ACD), NIH. The Director, NIH, will make the final selection of awardees based on the evaluations of the interview panel, the recommendations of the ACD, and programmatic considerations. Final selections will be announced publicly, and awards made, by the end of September 2009.
Applications that are complete and responsive to this FOA will be evaluated for scientific and technical merit by an appropriate peer review group in accordance with NIH peer review procedures (http://grants1.nih.gov/grants/peer/), using the review criteria stated below.
Applications will be evaluated based on the likelihood that the applicant will pursue a pioneering approach to a problem of relevance to biomedical or behavioral research, In particular, reviewers will evaluate:
The investigator: Evidence for the investigator’s claim of innovativeness/creativity (taking into consideration the investigator’s career stage) and the demonstrated ability of the investigator to devote at least 51% of his/her effort on to activities supported by the Pioneer Award.
The suitability for Pioneer Award mechanism: Evidence that the proposed project carries much higher levels of risk and potential impact than typical of NIH-supported research projects and evidence that the proposed project represents a distinctly new scientific direction.
Will be expected if an award is considered likely, or an explanation of why sharing is not possible.
Awardees will be notified in August 2009. Public announcement of the awards will be made in September 2009. Awards will begin September 30, 2009.
1. This award provides funding for an application submitted in response to RFA OD-09-001. This grant should be administered in accordance with the guidelines described in this specific announcement. These guidelines are in addition to the standard “Terms and Conditions” referenced in Section III of this Notice of Grant Award.
2a. When issuing statements, press releases, and other documents describing projects or programs funded as a NIH Director’s Pioneer Award, please use the following acknowledgement: "This work was funded by the National Institutes of Health through the NIH Director's Pioneer Award Program, grant number DP1-OD-xxxxxx. Information on the Pioneer Award Program is at http://nihroadmap.nih.gov/pioneer/.
2b. As indicated in the FOA, awardees are expected to commit at least 51% of their research effort to the project supported by the Pioneer Award.